Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
234.00    -12.50 (-4.91%)
Bid:
236.00
Ask:
248.00
Spread: 12.00 (5.085%)
Market Cap: £25.69m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Loan Conversion

9 Dec 2025 11:40

RNS Number : 8585K
Alkemy Capital Investments PLC
09 December 2025
 

9 December 2025

 

Alkemy Capital Investments Plc

Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £250,000 of principal and £513.70 of interest is being converted at £2.77, resulting in the issue of 90,572 ordinary shares of 2 pence each in the Company ("Ordinary Shares").

The Company will accordingly issue 90,572 new Ordinary Shares in the Company (the "New Ordinary Shares").

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 15 December 2025 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 10,662,592 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is committed to supplying battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, UK, TVL is developing a low-carbon, independent lithium supply chain for European battery manufacturers.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFKLFBELLXFBZ
Date   Source Headline
13th Nov 20237:00 amRNSTVL First Feedstock Deal
1st Nov 202311:20 amRNSCorporate Presentation
31st Oct 202311:00 amRNSInvestor Webinar
27th Oct 20238:00 amRNSInterim Results for Period Ended 31 July 2023
24th Oct 20237:00 amRNSVSA lifts target price to £15.30 per share
3rd Oct 20237:00 amRNSUpdate on Lithium Feedstock and Offtake
29th Sep 20237:00 amRNSTVL Grant Funding Secured
23rd Aug 20238:00 amRNSFirst Lithium Sulphate Plant Study
1st Aug 202310:00 amRNSAustralia’s first Lithium Sulphate Plant
18th Jul 202311:00 amRNSResult of AGM
5th Jul 202311:00 amRNSAppointment of SI Capital as Corporate Broker
23rd Jun 202312:30 pmRNSNotice of Annual General Meeting
6th Jun 20234:00 pmRNSGrant of Options
31st May 20238:00 amRNS£1.35m Fundraise and Director Participation
31st May 20237:55 amRNSAnnual Report & Financial Statements
12th May 20238:00 amRNSMOU on process to unlock major Lithium feedstock
28th Apr 20238:00 amRNSTVL Management Recruitment
26th Apr 20238:00 amRNSMOU with Altilium Metals for lithium feedstock
20th Apr 20238:00 amRNSCorporate Update
17th Apr 20237:00 amRNSUK Minister Port Hedland Site Visit
31st Mar 20234:35 pmRNSPrice Monitoring Extension
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSCMA highlights TVL’s strategic importance
1st Mar 20237:00 amRNSTVL Accelerates Lithium Supply With BritishVolt
7th Feb 20237:00 amRNSMOU with Recharge Industries
24th Jan 20237:00 amRNSFirst phase approval from the UK ATF
19th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSSite secured for Port Hedland Lithium plant
20th Dec 20227:00 amRNSLong Term Lease Agreed for TVL’s Lithium Facility
5th Dec 20229:00 amRNSCorporate Presentation
25th Nov 20227:00 amRNSApproval for Europe's biggest Lithium Plant
8th Nov 20227:00 amRNSAppointment of Lead Engineering Partner
27th Oct 20227:00 amRNSInterim Results
12th Oct 20229:30 amRNSTVL and bp trial Green Hydrogen
29th Sep 20227:00 amRNSCorporate Update
23rd Aug 20228:45 amRNSInitiation of Research Report by Shard Capital
15th Aug 20227:00 amRNSAgreement with Weardale Lithium
12th Aug 20225:00 pmRNSHolding(s) in Company
8th Aug 20223:20 pmRNSCorrection: Placing and Directors Purchase
8th Aug 20227:00 amRNSAustralia’s First Lithium Sulphate Plant
4th Aug 20228:00 amRNSGrant of Options
4th Aug 20227:00 amRNSOversubscribed Placing and Director Purchase
21st Jul 20227:00 amRNSLithium Feedstock Agreement with Traxys
20th Jul 20223:15 pmRNSResult of AGM
20th Jun 20227:00 amRNSInitiation of Research Coverage by VSA Capital
17th Jun 202212:00 pmRNSNotice of Annual General Meeting
7th Jun 20227:00 amRNSBrokers Visit World Class Wilton International
23rd May 20227:00 amRNSManufacturer confirms TVL’s ultra pure Lithium
18th May 20227:00 amRNSAnnual Report & Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.